FDA OKs Mylan’s biosimilar of Roche cancer drug Herceptin

Read more

Can Indian Pharma Inc find its lost mojo?

Read more

Policy experiences of 2017 for pharma sector

Read more

Pharma trends in 2018 and beyond

Read more

Tracking biosimilar trends

Read more

Poised for a strong growth

Read more

‘Patients and consumers will be looking for convenient and intuitive packaging formats’

Read more

Digitech: Revolutionising healthcare

Read more

Ramping up R&D— Key to success

Read more

A new era in pharma business

Read more